Insmed Incorporated
Price Action
Technical Summary
WEAKENINGInsmed Incorporated is in a technical downtrend, trading below key resistance levels with a broken trend structure. Relative strength is weak (RS Rating: 16), showing significant lag compared to the market leaders. Earnings growth of 46% provides fundamental context to the price action. Investors should exercise caution due to high volatility (52% annualized), which requires wider risk management.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $101.66 | +10.99% | ABOVE |
| 50 SMA | $110.22 | +2.38% | ABOVE |
| 100 SMA | $129.72 | -13.01% | BELOW |
| 150 SMA | $144.75 | -22.05% | BELOW |
| 200 SMA | $151.44 | -25.49% | BELOW |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is INSM in an uptrend right now?
INSM has a trend score of 1/4 based on Minervini's Stage Analysis. Currently showing broken structure - 1 of 4 trend criteria are met.
Is INSM overbought or oversold?
INSM's RSI (14) is 59. The stock is in neutral territory, neither overbought nor oversold.
Is INSM outperforming the market?
INSM has a Relative Strength (RS) Rating of 16 out of 99. INSM is currently lagging the broader market.
Where is INSM in its 52-week range?
INSM is trading at $112.84, which is 53% of its 52-week high ($212.75) and 18% above its 52-week low ($90.39).
How volatile is INSM?
INSM has a Beta of 0.58 and 52-week volatility of 52%. It's less volatile than the S&P 500 - generally more stable.